1-4 of 4
Robert W. Robey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor

Arup R. Chakraborty, Robert W. Robey, Victoria L. Luchenko, Zhirong Zhan, Richard L. Piekarz, Jean-Pierre Gillet, Andrew V. Kossenkov, Julia Wilkerson, Louise C. Showe, Michael M. Gottesman, Nathan L. Collie, Susan E. Bates
Journal: Blood
Blood (2013) 121 (20): 4115–4125.
https://doi.org/10.1182/blood-2012-08-449140
Published: 2013
Includes: Supplemental data
Journal Articles

In Vitro and In Vivo Inhibition of P-Glycoprotein (ABCB1) by a Novel Non-Substrate Compound: HG-829

Gisela Caceres, Ph.D., Robert W Robey, Ph.D., Lubomir Sokol, MD, PhD, Kathy Rocha McGraw, William J Fulp, Justine Clark, MS, Nicholas J Lawrence, Ph.D., Said Sebti, Ph.D., Susan E. Bates, MD, Alan F. List
Journal: Blood
Blood (2010) 116 (21): 3986.
https://doi.org/10.1182/blood.V116.21.3986.3986
Published: 2010
Journal Articles

Efflux of the Tyrosine Kinase Inhibitors Imatinib and Nilotinib (AMN107) Is Mediated by ABCB1 (MDR1)-Type P-Glycoprotein.

Marius Dohse, Robert W. Robey, Cornelia Brendel, Susan Bates, Andreas Neubauer, Christian Scharenberg
Journal: Blood
Blood (2006) 108 (11): 1367.
https://doi.org/10.1182/blood.V108.11.1367.1367
Published: 2006
Journal Articles

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

Richard L. Piekarz, Robert W. Robey, Zhirong Zhan, Ganesh Kayastha, Anousheh Sayah, Amina H. Abdeldaim, Sonia Torrico, Susan E. Bates
Journal: Blood
Blood (2004) 103 (12): 4636–4643.
https://doi.org/10.1182/blood-2003-09-3068
Published: 2004